Blog

Ilya Nechaev: How AI is transforming healthcare and clinical trials

Ilya Nechaev/LinkedIn

Oct 9, 2024, 11:01

Ilya Nechaev: How AI is transforming healthcare and clinical trials

Ilya Nechaev, Head of Medical Affairs at BostonGene, posted the following on LinkedIn:

“Healthcare & AI: how to be ready?

Just a few weeks ago, Sam Altman‘s essay, The Intelligence Age, highlighted AI’s transformational role.

For pharma, AI is already accelerating drug discovery, customizing treatments, and predicting outcomes with unprecedented accuracy. But what’s next for Medical Affairs?

Faster clinical trials – 100%, from the development of molecules and protocols to the inclusion and monitoring of patients, not using it now means not giving this opportunity to our patients.
Personalized patient engagement – 100%, we now have the tools to tailor approaches based on unique patient profiles, improving care quality and satisfaction.
Data responsibility – 100%, more data means higher ethical stakes and our role is pivotal in safeguarding data transparency and integrity

What can Medical Affairs do now?

Make data-driven, patient-centered decisions and
Embrace AI to enhance every step of the patient journey.

How do you see Medical Affairs shaping this AI-driven future? On October 19, let’s discuss this together at the webinar ‘Generative AI in Pharma – Five Years From Now.’”

AI Cancer research clinical trials data responsibility drug discovery healthcare Ilya Nechaev Medical Affairs OncoDaily Oncology personalized patient engagement Sam Altman

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage